These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
214 related articles for article (PubMed ID: 9349062)
1. A comparison of the infusion pharmacokinetics and pharmacodynamics of cisatracurium, the 1R-cis 1'R-cis isomer of atracurium, with atracurium besylate in healthy patients. Smith CE; van Miert MM; Parker CJ; Hunter JM Anaesthesia; 1997 Sep; 52(9):833-41. PubMed ID: 9349062 [TBL] [Abstract][Full Text] [Related]
2. Comparison of the pharmacodynamics and pharmacokinetics of an infusion of cis-atracurium (51W89) or atracurium in critically ill patients undergoing mechanical ventilation in an intensive therapy unit. Boyd AH; Eastwood NB; Parker CJ; Hunter JM Br J Anaesth; 1996 Mar; 76(3):382-8. PubMed ID: 8785138 [TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetics of 1R-cis 1'R-cis atracurium besylate (51W89) and plasma laudanosine concentrations in health and chronic renal failure. Eastwood NB; Boyd AH; Parker CJ; Hunter JM Br J Anaesth; 1995 Oct; 75(4):431-5. PubMed ID: 7488483 [TBL] [Abstract][Full Text] [Related]
6. The pharmacokinetics and pharmacodynamics of the stereoisomers of mivacurium in patients receiving nitrous oxide/opioid/barbiturate anesthesia. Lien CA; Schmith VD; Embree PB; Belmont MR; Wargin WA; Savarese JJ Anesthesiology; 1994 Jun; 80(6):1296-302. PubMed ID: 8010476 [TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of cisatracurium in patients with end-stage liver disease undergoing liver transplantation. De Wolf AM; Freeman JA; Scott VL; Tullock W; Smith DA; Kisor DF; Kerls S; Cook DR Br J Anaesth; 1996 May; 76(5):624-8. PubMed ID: 8688259 [TBL] [Abstract][Full Text] [Related]
8. A comparison of cisatracurium and atracurium: onset of neuromuscular block after bolus injection and recovery after subsequent infusion. Mellinghoff H; Radbruch L; Diefenbach C; Buzello W Anesth Analg; 1996 Nov; 83(5):1072-5. PubMed ID: 8895288 [TBL] [Abstract][Full Text] [Related]
9. Pharmacokinetics and dynamics of atracurium infusions after paediatric orthotopic liver transplantation. Chow B; Bowden MI; Ho E; Weatherley BC; Bion JF Br J Anaesth; 2000 Dec; 85(6):850-5. PubMed ID: 11732518 [TBL] [Abstract][Full Text] [Related]
10. Newer neuromuscular blocking agents: how do they compare with established agents? Sparr HJ; Beaufort TM; Fuchs-Buder T Drugs; 2001; 61(7):919-42. PubMed ID: 11434449 [TBL] [Abstract][Full Text] [Related]
11. [The clinical pharmacology of new benzylisoquinoline-diester compounds, with special consideration of cisatracurium and mivacurium]. Savarese JJ; Lien CA; Belmont MR; Wastila WB Anaesthesist; 1997 Oct; 46(10):840-9. PubMed ID: 9424966 [TBL] [Abstract][Full Text] [Related]
12. Pharmacodynamics and pharmacokinetics of cisatracurium in geriatric surgical patients. Ornstein E; Lien CA; Matteo RS; Ostapkovich ND; Diaz J; Wolf KB Anesthesiology; 1996 Mar; 84(3):520-5. PubMed ID: 8659778 [TBL] [Abstract][Full Text] [Related]
13. Effect of age on cis-atracurium besylate pharmacokinetics following a single 1 mg kg Aguilar A; Andaluz A; Moll X; Cristòfol C; García F Vet Anaesth Analg; 2019 Sep; 46(5):643-651. PubMed ID: 31155378 [TBL] [Abstract][Full Text] [Related]
14. A comparison of the neuromuscular blocking effects and reversibility of cisatracurium and atracurium. Carroll MT; Mirakhur RK; Lowry D; Glover P; Kerr CJ Anaesthesia; 1998 Aug; 53(8):744-8. PubMed ID: 9797517 [TBL] [Abstract][Full Text] [Related]
15. The in vitro degradation of cisatracurium, the R, cis-R'-isomer of atracurium, in human and rat plasma. Welch RM; Brown A; Ravitch J; Dahl R Clin Pharmacol Ther; 1995 Aug; 58(2):132-42. PubMed ID: 7648763 [TBL] [Abstract][Full Text] [Related]
16. Comparison of cisatracurium and vecuronium by infusion in neonates and small infants after congenital heart surgery. Reich DL; Hollinger I; Harrington DJ; Seiden HS; Chakravorti S; Cook DR Anesthesiology; 2004 Nov; 101(5):1122-7. PubMed ID: 15505447 [TBL] [Abstract][Full Text] [Related]
17. Cisatracurium-induced neuromuscular blockade is affected by chronic phenytoin or carbamazepine treatment in neurosurgical patients. Richard A; Girard F; Girard DC; Boudreault D; Chouinard P; Moumdjian R; Bouthilier A; Ruel M; Couture J; Varin F Anesth Analg; 2005 Feb; 100(2):538-544. PubMed ID: 15673889 [TBL] [Abstract][Full Text] [Related]
18. Pharmacokinetics and pharmacodynamics of cisatracurium in young and elderly adult patients. Sorooshian SS; Stafford MA; Eastwood NB; Boyd AH; Hull CJ; Wright PM Anesthesiology; 1996 May; 84(5):1083-91. PubMed ID: 8624002 [TBL] [Abstract][Full Text] [Related]
19. Clinical pharmacokinetics of the newer neuromuscular blocking drugs. Atherton DP; Hunter JM Clin Pharmacokinet; 1999 Mar; 36(3):169-89. PubMed ID: 10223167 [TBL] [Abstract][Full Text] [Related]
20. Neuromuscular blocking effects and train-of-four fade with cisatracurium: comparison with other nondepolarising relaxants. Carroll MT; Mirakhur RK; Lowry DW; McCourt KC; Kerr C Anaesthesia; 1998 Dec; 53(12):1169-73. PubMed ID: 10193219 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]